Related by context. Frequent words. (Click for all words.) 56 Complete Response 56 Phenoptin 56 Panzem R 55 ISTODAX 55 FDA Accepts 55 alvimopan 54 voclosporin 54 Diamyd R 54 Pirfenidone 54 FavId 53 adecatumumab 53 Pivotal Phase III 53 Vilazodone 53 Fibrillex TM 52 Investigational Device Exemption 52 Avanafil 52 BLA submission 52 Clinical Trial Application 52 Diabetic Macular Edema 52 Icatibant 51 IND submission 51 NEBIDO 51 prGCD 51 Apixaban 51 Shigamabs ® 51 PMA submission 51 PXD# 51 phase IIa 51 Junovan 51 registrational 51 EOquin 51 Marketing Authorization Application 51 KRN# 50 phase IIb clinical 50 Pivotal Phase 50 Phase Ib clinical 50 PEG SN# 50 SILENOR TM 50 Phase 1b trial 50 MOZOBIL 50 liprotamase 50 alogliptin 50 Pulmonary Arterial Hypertension 50 Phase IIB 50 http:/www.clinicaltrials.gov 50 Orphan Drug status 50 liposomal formulation 50 Belinostat 50 ICA # 50 tezampanel 50 DDP# 50 APOPTONE 50 talactoferrin 49 ponatinib 49 Clinical Trial Results 49 teduglutide 49 Phase 2a trial 49 registrational trial 49 Omigard 49 ganetespib 49 Pivotal Trial 49 ATL# [001] 49 BEMA TM Fentanyl 49 optimal dosing 49 anticancer compound 49 Bicifadine 49 elotuzumab 49 PS# [001] 49 Phase 1b clinical 49 Orphan Drug Status 49 Nasdaq Hearings Panel 49 Biologics License Application BLA 49 Diamyd ® 49 Azedra 49 Phase IIb trials 49 subcutaneous formulation 49 PREOS 49 Chronic Heart Failure 49 Phase IIa trial 49 vilazodone 49 Phase Ib 48 FDA approvable letter 48 NASDAQ Listing 48 Phase IIa clinical trials 48 Benign Prostatic Hyperplasia 48 www.combinatorx.com 48 pharmacokinetics PK 48 Cloretazine R VNP#M 48 celgosivir 48 www.cardiome.com 48 Phase III Clinical Trial 48 Pharmacokinetic 48 Amigal 48 orphan designation 48 Phase Ia 48 OX1 48 EndoTAG TM -1 48 ATHX 48 oritavancin 48 alagebrium 48 Bronchitol